Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 28 results.
User Information
Export Records
  1. 1.   HTLV-1 p13 Protein Hijacks Macrophage Polarization and Promotes T-Cell Recruitment
  2. Moles, Ramona; Omsland, Maria; Pise-Masison, Cynthia A; Subleski,Jeffrey; McVicar,Daniel; Sarkis, Sarkis; Gutowska, Anna; Schifanella, Luca; Doster, Melvin; Washington-Parks, Robyn; Ciminale, Vincenzo; Franchini, Genoveffa
  3. Viruses. 2025, Mar 26; 17(4): 471.
  1. 2.   MoMo30 Binds to SARS-CoV-2 Spike Variants and Blocks Infection by SARS-CoV-2 Pseudovirus
  2. DeBarros, Kenya; Khan, Mahfuz; Coleman, Morgan; Bond, Vincent C; Floyd, Virginia; Gbodossou, Erick; Diop, Amad; Krumpe,Lauren; O'Keefe,Barry; Powell, Michael D
  3. Viruses. 2024, Sep 07; 16(9):
  1. 3.   Single-nucleus RNA sequencing reveals loss of DCT1 renal tubules in HIV Vpr transgenic mice
  2. Latt, Khun Zaw; Yoshida, Teruhiko; Shrivastav, Shashi; Abedini, Amin; Reece, Jeff M; Sun, Zeguo; Lee, Hewang; Okamoto, Koji; Dagur, Pradeep; Ishimoto, Yu; Heymann, Jurgen; Zhao,Yongmei; Chung, Joon-Yong; Hewitt, Stephen; Jose, Pedro A; Lee, Kyung; He, John Cijiang; Winkler,Cheryl; Knepper, Mark A; Kino, Tomoshige; Rosenberg, Avi Z; Susztak, Katalin; Kopp, Jeffrey B
  3. The American Journal of Pathology. 2024, Jul 18;
  1. 4.   S-acylation of SARS-CoV-2 Spike Protein: Mechanistic Dissection, In Vitro Reconstitution and Role in Viral Infectivity
  2. Puthenveetil, Robbins; Lun, Cheng Man; Murphy, R Elliot; Healy, Liam B; Vilmen,Geraldine; Christenson, Eric T; Freed,Eric; Banerjee, Anirban
  3. The Journal of biological chemistry. 2021, Oct; 297(4): 101112.
  1. 5.   Specificity of the HIV-1 Protease on Substrates Representing the Cleavage Site in the Proximal Zinc-Finger of HIV-1 Nucleocapsid Protein
  2. Motyan, Janos Andras; Miczi, Mario; Oroszlan, Stephen; Tozser, Jozsef
  3. Viruses. 2021, Jun; 13(6):
  1. 6.   Across the Hall from Pioneers
  2. Rein,Alan
  3. Viruses . 2021, Mar; 13(3):
  1. 7.   HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence
  2. Zhao, Xue Zhi; Métifiot, Mathieu; Kiselev, Evgeny; Kessl, Jacques J; Maddali, Kasthuraiah; Marchand, Christophe; Kvaratskhelia, Mamuka; Pommier, Yves; Burke, Terrence
  3. Molecules . 2018, Aug; 23(8): pii: E1858.
  1. 8.   Investigation of Griffithsin's Interactions with Human Cells Confirms Its Outstanding Safety and Efficacy Profile as a Microbicide Candidate
  2. Kouokam, J. C.; Huskens, D.; Schols, D.; Johannemann, A.; Riedell, S. K.; Walter, W.; Walker, J. M.; Matoba, N.; O'Keefe, B. R.; Palmer, K. E.
  3. Plos One. 2011, Aug; 6(8):
  1. 9.   Monomerization of Viral Entry Inhibitor Griffithsin Elucidates the Relationship between Multivalent Binding to Carbohydrates and anti-HIV Activity
  2. Moulaei, T.; Shenoy, S. R.; Giomarelli, B.; Thomas, C.; McMahon, J. B.; Dauter, Z.; O'Keefe, B. R.; Wlodawer, A.
  3. Structure. 2010, Sep; 18(9): 1104-1115.
  1. 10.   Multivalent Interactions with gp120 Are Required for the Anti-HIV Activity of Cyanovirin
  2. Liu, Y. A.; Carroll, J. R.; Holt, L. A.; McMahon, J.; Giomarelli, B.; Ghirl, a
  3. Biopolymers. 2009 92(3): 194-200.
  1. 11.   Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
  2. O'Keefe, B. R.; Vojdani, F.; Buffa, V.; Shattock, R. J.; Montefiori, D. C.; Bakke, J.; Mirsalis, J.; d'Andrea, A. L.; Hume, S. D.; Bratcher, B.; Saucedo, C. J.; McMahon, J. B.; Pogue, G. P.; Palmer, K. E.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(15): 6099-6104.
  1. 12.   Effects of Gag mutation and processing on retroviral dimeric RNA maturation
  2. Fu, W.; Dang, Q.; Nagashima, K.; Freed, E. O.; Pathak, V. K.; Hu, W. S.
  3. Journal of Virology. 2006, FEB; 80(3): 1242-1249.
  1. 13.   Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope
  2. Raviv, Y.; Viard, M.; Bess, J. W.; Chertova, E.; Blumenthal, R.
  3. Journal of Virology. 2005, OCT; 79(19): 12394-12400.
  1. 14.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
  1. 15.   Association of Ebola virus matrix protein VP40 with microtubules
  2. Ruthel, G.; Demmin, G. L.; Kallstrom, G.; Javid, M. P.; Badie, S. S.; Will, A. B.; Nelle, T.; Schokman, R.; Nguyen, T. L.; Carra, J. H.; Bavari, S.; Aman, M. J.
  3. Journal of Virology. 2005, APR; 79(8): 4709-4719.
  1. 16.   Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation
  2. Vazquez, N.; Greenwell-Wild, T.; Marinos, N. J.; Swaim, W. D.; Nares, S.; Ott, D. E.; Schubert, U.; Henklein, P.; Orenstein, J. M.; Sporn, M. B.; Wahl, S. M.
  3. Journal of Virology. 2005 79(7): 4479-4491.
  1. 17.   Action of Anti-HIV drugs and resistance: Reverse transcriptase inhibitors and protease inhibitors
  2. Imamichi, T.
  3. Current Pharmaceutical Design. 2004 10(32): 4039-4053.
  1. 18.   Proteolytic events of HIV-1 replication as targets for therapeutic intervention
  2. Tozser, J.; Oroszlan, S.
  3. Current Pharmaceutical Design. 2003 9(22): 1803-1815.
  1. 19.   Effect of sequence polymorphism and drug resistance on two HIV- 1 Gag processing sites
  2. Feher, A.; Weber, I. T.; Bagossi, P.; Boross, P.; Mahalingam, B.; Louis, J. M.; Copeland, T. D.; Torshin, I. Y.; Harrison, R. W.; Tozser, J.
  3. European Journal of Biochemistry. 2002 269(16): 4114-4120.
  1. 20.   Testing of new agents in childhood cancer preclinical models: Meeting summary
  2. Houghton, P. J.; Adamson, P. C.; Blaney, S.; Fine, H. A.; Gorlick, R.; Haber, M.; Helman, L.; Hirschfeld, D.; Hollingshead, M. G.; Israel, M. A.; Lock, R. B.; Maris, J. M.; Merlino, G.; Patterson, W.; Reynolds, C. P.; Shannon, K.; Yu, A.; Yu, J.; Smith, M. A.
  3. Clinical Cancer Research. 2002 8(12): 3646-3657.
  1. 21.   Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 Gag by using DNA expression vectors that target Gag antigen to the secretory pathway
  2. Qiu, J. T.; Liu, B. D.; Tian, C. J.; Pavlakis, G. N.; Yu, X. F.
  3. Journal of Virology. 2000 74(13): 5997-6005.
  1. 22.   SDS polyacrylamide gel electrophoresis
  2. Maizel, J. V.
  3. Trends in Biochemical Sciences. 2000 25(12): 590-592.
  1. 23.   Stabilization from autoproteolysis and kinetic characterization of the human T-cell leukemia virus type 1 proteinase
  2. Louis, J. M.; Oroszlan, S.; Tozser, J.
  3. Journal of Biological Chemistry. 1999 274(10): 6660-6666.
  1. 24.   Effect of substrate residues on the P2 ' preference of retroviral proteinases
  2. Boross, P.; Bagossi, P.; Copeland, T. D.; Oroszlan, S.; Louis, J. M.; Tozser, J.
  3. European Journal of Biochemistry. 1999 264(3): 921-929.
  1. 25.   Expression and characterization of human foamy virus proteinase
  2. Fenyofalvi, G.; Bagossi, P.; Copeland, T. D.; Oroszlan, S.; Boross, P.; Tozser, J.
  3. Febs Letters. 1999 462(3): 397-401.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel